Depatuxizumab Mafodotin (Depatux-M) plus temozolomide in recurrent glioblastoma patients: real-world experience from a multicenter study of Italian Association of Neuro-Oncology (AINO) - Padovan, M; Eoli, M; Pellerino, A (Cancers (Basel), 2021)